BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 4808327)

  • 1. A controlled study of the clinical effectiveness of urine test results in a methadone maintenance program.
    Grevert P; Weinberg A
    Proc Natl Conf Methadone Treat; 1973; 2():1052-9. PubMed ID: 4808247
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased utilization of counseling related to dose reduction in methadone maintenance.
    Creel S; Berkson R; Reilly J; Bulter P; Walker B; Carrozza L; Morrison J; O'Connell R; Patch V
    Proc Natl Conf Methadone Treat; 1973; 2():957-62. PubMed ID: 4808326
    [No Abstract]   [Full Text] [Related]  

  • 3. [Risk factors associated with continued heroin use during methadone maintenance treatment in Guizhou province, China].
    Liu EW; Wu ZY; Liang T; Shen LM; Zhong H; Wang B; Roger D
    Zhonghua Yu Fang Yi Xue Za Zhi; 2008 Dec; 42(12):875-8. PubMed ID: 19141219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of ancillary facilities within methadone maintenance treatment program: quality control of the laboratory and of the pharmacy.
    Sohn D; Simon J; Melkonian V; Sohn S
    Proc Natl Conf Methadone Treat; 1973; 2():1079-84. PubMed ID: 4808251
    [No Abstract]   [Full Text] [Related]  

  • 5. Disulfiram (Antabuse) in the treatment of methadone maintenance alcoholics.
    Pascarelli EF; Eaton C
    Proc Natl Conf Methadone Treat; 1973; 1():316-23. PubMed ID: 4808164
    [No Abstract]   [Full Text] [Related]  

  • 6. [Methadone program in the USA. Experience and problems].
    Riedesser P
    Med Klin; 1974 Apr; 69(16):671-80. PubMed ID: 4600421
    [No Abstract]   [Full Text] [Related]  

  • 7. Methadone maintenance treatment (MMT): a review of historical and clinical issues.
    Joseph H; Stancliff S; Langrod J
    Mt Sinai J Med; 2000; 67(5-6):347-64. PubMed ID: 11064485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opiate-ethanol interactions: implications for the biological basis and treatment of combined addictive diseases.
    Kreek MJ
    NIDA Res Monogr; 1988; 81():428-39. PubMed ID: 3136382
    [No Abstract]   [Full Text] [Related]  

  • 9. Methadone dosage levels, positive urine tests and length of time in a methadone treatment program.
    Langley M; Norris B; Parker L
    Proc Natl Conf Methadone Treat; 1973; 2():963-71. PubMed ID: 4808327
    [No Abstract]   [Full Text] [Related]  

  • 10. Methadone and naloxone in combination (Naldone) for the treatment of heroin addicts.
    Caruso FS; Gordon M; Pachter IJ
    Proc Natl Conf Methadone Treat; 1973; 2():1336-41. PubMed ID: 4215978
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.